May 14, 2020 / 11:19 AM / 15 days ago

BRIEF-Vascular Biogenics Q1 Loss Per Share $0.15

May 14 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 REVENUE ESTIMATE $162,000 — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-0.17 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below